3654 results for «372»

Filter By

3654 results

CTO: imaging and devices

14 Apr 2021 – From EuroPCR 2021

Thanks to this session, learn how to recanalize a chronic total occlusion of the right coronary artery, how IVUS can facilitate and guide PCI to ostial left circumflex CTO, how hi-tech devices are also needed in calcified artery occlusions, and even more!

EuroPCR 2021 CTO: imaging and devices

Primary PCI: surprise, surprise!

14 Apr 2021 – From EuroPCR 2021

Thanks to this session, view an unusual posterior wall infarction, study a "nightmare" acute coronary syndrome case in the EP Lab, consider STEMI with lots of clots, and more! 

EuroPCR 2021 Primary PCI: surprise, surprise!

Coronary protection during TAVI - Many roads lead to Rome

28 Apr 2021 – From EuroPCR 2021

Thanks to this session, become familiar with techniques for left main coronary protection in ViV TAVI, get prepared for challenges of ostial coronary artery stenosis in a patient planned for TAVR, find out more about ViV TAVI with high risk of bilateral ostium occlusion, and more!

EuroPCR 2021 Coronary protection - Many roads lead to Rome

TAVI in a grey zone - Part 2

28 Apr 2021 – From EuroPCR 2021

Thanks to this session, study TAVI in case of Fabry disease, analyze severe aortic valve stenosis with cardiogenic shock requiring ECMO, get the chance to examine TAVI in challenging valve position with calcified aortic valve, and much more!

EuroPCR 2021 - TAVI in a grey zone - Part 2

Challenging scenarios in STEMI patients

14 Apr 2021 – From EuroPCR 2021

In this session, you'll discover challenging STEMI cases: STEMI with cardiogenic shock and no vascular access for mechanical support, anterior STEMI with critical LMCA stenosis, double culprits STEMI, and much more!

EuroPCR 2021 Challenging scenarios in STEMI patients

Stent dislodgement / Fracture - Part 2

14 Apr 2021 – From EuroPCR 2021

This session will help you learn more about bail out strategies in case of stent fracture, especially when facing calcified lesions, analyze post left main stenting sparkle in aorta, find out more about floating left anterior descending artery stents, and more!

EuroPCR 2021 Stent dislodgement / Fracture - Part 2

Percutaneous treatment of tricuspid regurgitation in 2021 - part 1

28 Apr 2021 – From EuroPCR 2021

This session will enable you to find out more about refractory heart failure in severe stand-alone tricuspid regurgitation, to study the one-shot transcatheter solution for torrential tricuspid regurgitation, and to witness full percutaneous three in one.

EuroPCR 2021 Percutaneous treatment of tricuspid regurgitation in 2021 - part 1

Coronary dissection - Part 1

28 Apr 2021 – From EuroPCR 2021

This session will help you know how to manage an iatrogenic intramural haematoma, how to treat a large pseudoaneurysm following PCI in SCAD, how to dissect flow-limiting spontaneous coronary, and much more!

EuroPCR 2021 Coronary dissection - Part 1

Coronary sinus reducer for microvascular angina

28 Feb 2020

A 61-year-old man with a history of 2-vessel coronary artery stenting, hypertension and type-2 diabetes mellitus was admitted 5 times within September 2017 and November 2018 for recurrent angina CCS class III-IV refractory to therapy with nitrates, b-blockers and ranolazine in maximally tolerated doses...

Coronary sinus reducer for microvascular angina

Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation – The WATCH-TAVR Trial

26 Oct 2023

Panos Xaplanteris provides his take on WATCH-TAVR results which were presented by Samir R. Kapadia at TCT Congress 2023.

Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - The WATCH TAVR Trial

Panagiotis Xaplanteris

Author

Panagiotis Xaplanteris
Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - The WATCH TAVR Trial

OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease

04 Nov 2021

Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG

Five-year outcomes of the randomised trial of fractional flow reserve guided PCI compared to coronary artery bypass grafting: FAME 3

02 Apr 2025

Kalaivani Mahadevan provides her take on the five-year outcomes of the FAME 3 trial presented by William F. Fearon at ACC.25 in Chicago.

Kalaivani Mahadevan

Author

Kalaivani Mahadevan
FFR-guided PCI vs CABG: 5-year results of the FAME 3 trial

The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

22 Mar 2022

Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022. 

Daniele Giacoppo

Author

Daniele Giacoppo
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

29 Mar 2025

Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.

Nicola Ammirabile

Author

Nicola Ammirabile
Daniele Giacoppo

Author

Daniele Giacoppo
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
Didn’t find what you were looking for?